Plasma stearoyl-CoA desaturase activity indices and bile acid concentrations after a low-fat meal: association with a genetic variant in the FTO gene by Skúladóttir, Guðrún Valgerður et al.
© 2018 Skuladottir et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms. 
php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work 
you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For 
permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018:11 611–618
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
611
O r i g i n a l  r e S e a r c h
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/DMSO.S175730
Plasma stearoyl-coa desaturase activity indices 
and bile acid concentrations after a low-fat meal: 
association with a genetic variant in the FTO gene
gudrun Valgerdur 
Skuladottir1,2  
harpa Oskarsdottir1 
claudia Pisanu2,3  
Marcus Sjödin4  
Johan lindberg4  
Jessica Mwinyi2  
helgi Birgir Schiöth2
1Department of Physiology, Faculty 
of Medicine, University of iceland, 
reykjavik, iceland; 2Department 
of neuroscience, Functional 
Pharmacology, Uppsala University, 
Uppsala, Sweden; 3Department of 
Biomedical Sciences, University 
of cagliari, cagliari, italy; 4Swetox, 
Karolinska institutet, Unit of 
Toxicological Sciences, Södertälje, 
Sweden
Purpose: Dietary macronutrient composition, stearoyl-CoA desaturase (SCD) activity indices, 
and primary bile acid (BA) concentrations are among the factors that have been associated 
with lipid metabolism and contributed to obesity. We investigated the association between the 
polymorphic expression of the fat mass and obesity-associated (FTO) gene and its relationship 
with SCD activity indices and primary BA concentrations after a low-fat meal.
Subjects and methods: Blood plasma samples were collected from 56 young (20–36 years) 
healthy subjects with different rs9939609 FTO genotypes. Fasting and post-meal (2 hours after 
a low-fat breakfast) blood samples were collected on the subsequent morning for the analysis 
of DNA methylation, SCD activity indices (product-to-precursor fatty acid ratios; 16:1n-7/16:0 
and 18:1n-9/18:0), and chenodeoxycholic acid (CDCA) and cholic acid (CA) concentrations. 
Expression of lipogenic genes was investigated post-meal to assess the relationship between 
the CDCA and CA concentrations and mRNA levels of lipogenic genes.
Results: The FTO AA (obesity risk) genotype group (n=18) had higher (P<0.05) post-meal 
SCD-16 activity index than the FTO TT (wild type) genotype group (n=26). In both the FTO 
TT (n=16) and AA (n=8) genotype groups, the post-meal concentrations of CDCA and CA were 
lower (P<0.05) compared with the fasted state. No difference in BA concentrations between 
the FTO TT and AA genotype groups in both meal states was observed. After adjusting for the 
body mass index, the highest 50% post-meal concentrations of CA were inversely (P=0.010) 
correlated with the level of mRNA SCD expression.
Conclusion: FTO AA carriers may be at a higher risk for obesity through higher SCD activity in 
a low-fat diet environment. This effect may be partly pronounced by very low CA concentrations.
Keywords: rs9939609, dietary fat, SCD activity, cholic acid, lipid metabolism
Introduction
Obesity is a complex disease resulting from the interactions of a wide variety of 
hereditary and environmental factors and is the major cause of human morbidity as 
there is an increased mortality of overweight and obesity.1–3 The first common genetic 
polymorphisms to be associated with increased body weight and obesity were the 
genetic variants of the fat mass and obesity-associated (FTO) gene,4 predominantly 
the single-nucleotide polymorphism (SNP) rs9939609 within intron one of the FTO 
genes.5 Both animal and human studies have indicated that dietary macronutrient 
composition may modify the association between the FTO variant and obesity. How-
ever, the association between FTO gene expression and dietary macronutrient intake 
is somewhat controversial.6,7
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Body mass index (BMI) is associated with the induction 
of triglyceride (TG) synthesis, which is highly dependent 
on stearoyl-CoA desaturase 1 (SCD1) gene expression.8 The 
enzyme SCD, predominantly expressed in the liver, plays a 
central role in the desaturation of saturated fatty acids and has 
been associated with the onset of obesity and obesity-related 
diseases.9–12 The SCD activity index (product-to-precursor 
fatty acid ratios; 16:1n-7/16:0 and 18:1n-9/18:0) derived from 
total lipids in plasma explained 44% of the variance in TGs, 
when human subjects were exposed to a high carbohydrate 
diet.9 According to the literature, high-carbohydrate diets act 
through modulation of hepatic SCD activity and increase the 
conversion of carbohydrates to monounsaturated fatty acids 
(16:1n-7 and 18:1n-9). This step enhances hepatic TG synthe-
sis, secretion, and storage in the adipose tissue, contributing 
to the development of obesity.11 Furthermore, animal studies 
have shown that the hepatic expression of the Scd1 gene is 
differentially affected by dietary content of carbohydrate and 
lipid, indicating that macronutrient diets affect lipid metabo-
lism in the liver via epigenetic mechanisms.13
Bile acids (BAs) are recognized as nutrient signaling 
hormones in the body and regulate their own synthesis 
and enterohepatic circulation through the activation of 
various signaling pathways, along with maintaining TG, 
cholesterol, glucose, and energy homeostasis.14 The pri-
mary BAs in humans, chenodeoxycholic acid (CDCA) and 
cholic acid (CA), are synthesized from cholesterol in liver 
hepatocytes,15 where they are natural ligands of the nuclear 
transcription factor farnesoid X receptor (FXR).16 Studies 
suggest that FXR plays a role in mediating the TG-lowering 
effects of BAs by reducing the expression of lipogenic genes 
and their regulators, including the SCD enzyme.17,18 It is 
indicated that one of the underlying mechanisms of FXR 
in preventing hepatic TG accumulation is due to the activa-
tion of FXR-mediated small heterodimer partner (SHP).17 
Moreover, CA-treated animal models of hypertriglyceride-
mia significantly reduced the expression of genes encoding 
enzymes involved in fatty acid and TG biosynthesis, such 
as SCD-1, in liver.17.
Today, the impact of dietary macronutrient composition 
is controversially discussed regarding the field of genetic 
factors that are involved in the etiology of obesity. We, there-
fore, wanted to investigate the effect of a low-fat breakfast 
on plasma SCD activity indices and concentrations of the 
primary BAs, CDCA and CA, in young and healthy subjects 
with focus on different rs9939609 FTO alleles. Importantly, 
we also investigated the relationship between the post-meal 
plasma concentrations of CDCA and CA and their associa-
tions with the expression of the lipogenic genes, SCD, FXR, 
and SHP, to obtain a further insight into the role of BA in 
lipid homeostasis under different strong lipogenic conditions 
taking FTO genotype and macronutrient composition of a 
diet into an account.
Subjects and methods
Subjects
This study is a part of a larger project aimed at recruiting 
healthy volunteers to investigate the epigenetic influences on 
food intake and metabolic effects in subjects carrying genetic 
variants predisposing to obesity, such as the common risk 
variant rs9939609 in the FTO gene. Inclusion and exclusion 
criteria have been previously described.19 This study was 
registered with ClinicalTrials.gov LSF008786. A total of 56 
young (median age 25.5 years, range 20–36 years) healthy 
subjects (86% men and 14% women) of three genotypes of 
the FTO gene were recruited. Of whom, 18 subjects were 
homozygous for the FTO rs9939609 obesity-risk A allele 
(FTO AA genotype group), 26 subjects were homozygous 
for the FTO rs9939609 wild-type T allele (FTO TT genotype 
group), and 12 subjects were heterozygous for the FTO 
rs9939609 obesity-risk A allele (FTO AT genotype group). 
Written informed consent was obtained from each participant 
included in the study, and the study protocol conforms to the 
ethical guidelines of the 1975 Declaration of Helsinki. The 
study was approved by the local ethical committee in Uppsala 
(EPN), number: 2010/201.
Study design
After an overnight (10–12 hours) fast, the subjects were 
admitted to the University of Uppsala at 9.00 am and the 
first blood samples were collected in EDTA tubes (fasted 
state). Subsequently, the subjects were taken a breakfast 
containing one jar of Kvarg Arla (0.1% fat), one piece of 
Fruktkusar bread, and three slices of Leerdammer cheese. 
The total energy of the diet was 581 kcal, which provided 
37% as carbohydrate (13.6% glucose), 18% as fat (10% 
saturated fat), and 45% as protein. The weight and height of 
subjects were recorded. Two hours after the breakfast, blood 
samples were collected again (post-meal state). The fasting 
and post-meal plasma samples were separated from whole 
blood samples, frozen at –80°C, and stored until fatty acid 
and BA analyses.
Determination of ScD activity indices
The analysis of fatty acids in plasma phospholipids (PL) was 
carried out at the University of Iceland. The total plasma 
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lipid fraction was extracted with chloroform–methanol (2:1, 
v/v), using a well-established method.20 PL were separated 
on a thin layer chromatograph plate using the solvent system 
petroleum ether/diethyl ether/acetic acid (80:20:1, v/v/v). The 
PL fatty acids were methylated with 14% boron trifluoride 
in methanol, and the fatty acid methyl esters (FAME) were 
analyzed by an HP Series II 5890 A, Gas Chromatograph 
(Hewlett Packard Co/Agilent Technologies,  Palo Alto, CA, 
USA). The FAME were identified and calibrated against 
commercial standards (Sigma Chemical Co./Nu-Check-Prep, 
Elysian, MN, USA). The results were expressed as percentage 
of total fatty acids in plasma PL. Activity indices of SCD-
16 and SCD-18 were determined calculating the ratios of 
16:1n-7/16:0 and 18:1n-9/18:0, respectively, derived from 
plasma PL.
Determination of Bas
The analysis of CDCA and CA in plasma of a subgroup of 
the FTO TT genotype (n=16) and FTO AA genotype (n=8) 
was carried out at the Karolinska Institutet, Unit of Toxico-
logical Sciences (Swetox). Briefly, a total of 60 µL of plasma 
collected at fasted state and post-meal state were mixed with 
methanol containing isotopically labeled internal standards 
of d4-CA (10 nM) and d4-CDCA (20 nM). The precipitated 
proteins were removed by centrifugation, and the supernatant 
was subjected for LC–MS/MS analysis. The BAs were chro-
matographically separated on an Acquity™ (Waters, Milford, 
MA, USA) using gradient elution (solvent A: 10 mM NH4Ac, 
pH 5; solvent B: acetonitrile) on a 100×2.1 mm HSS T3 col-
umn (Waters, Milford, MA, USA). The mass spectrometer 
was a Xevo™ TQD (Waters, Milford, MA, USA) operating 
in multiple reaction monitoring negative electrospray ioniza-
tion mode. The quantification was achieved using external 
calibrators (n=6) prepared in methanol. Interleaved with 
the primary samples, a set of QC samples at three different 
concentration levels were also analyzed. The used method 
covered a set of 67 conjugated and unconjugated BAs. For this 
report, only the primary BAs, CA and CDCA, were quantified 
and subjected for further statistical analysis.
gene expression
For each subject, fasting and post-meal blood samples 
were collected into PAXgene Blood RNA tubes and RNA 
extracted using the PreAnalytiX PAXgene Blood RNA Kit 
(Qiagen NV, Venlo, the Netherlands). RNA concentration 
and quality were evaluated using the NanoDrop Technologies 
ND-1000 spectrophotometer and the Agilent 2100 Bioana-
lyzer system, respectively. Total RNA (250 ng) from each 
sample was used to obtain amplified and biotinylated sense 
strand complementary DNA from the expressed genome, and 
RNA expression was measured using the GeneChip Human 
Gene 2.1 ST arrays as previously described19 at the Uppsala 
University Biomedical Center. In the present study, only 
mRNA levels of selected genes (SCD, FXR, and SHP) were 
extracted and analyzed.
Statistical analyses
Kruskal–Wallis test was used to compare the data of age and 
BMI between the FTO TT, AT, and AA genotype groups. 
Differences in plasma PL levels of 16:0, 16:1n-7, 18:0, and 
18:ln-9 and the ratios 16:1n-7/16:0 and 18:ln-9/18:0, fasted 
and 2 hours after the low-fat breakfast, within each FTO TT, 
AT, and AA genotype groups, and between those groups were 
compared with one-way ANOVA and post hoc Tukey test. A 
P-value of <0.05 was considered to be statistically significant.
The BAs, CDCA and CA, with nonmissing values in
≥90% of subjects were selected. Values under the detect-
ability concentrations were coded as missing. The Shapiro–
Wilk test was used to check the normality of distribution.
To compare concentrations of normally or nonnormally
distributed BA concentrations between FTO AA and TT
genotype groups, Student’s t-test and Mann–Whitney test
were used, respectively. In the second step, differences in BA
concentrations between fasted and post-meal states (effect
of breakfast) were compared using a nonparametric paired
test (Wilcoxon signed-rank test) in both FTO TT and AA
genotype groups. Analyses were conducted using SPSS v.20.
mRNA levels were available for SCD, FXR, and SHP 
genes. Transcriptomic raw intensity data were normal-
ized using the RNA algorithm with the oligo package in R 
(v.3.3.1). Duplicated and nonannotated probes were excluded 
using the genefilter package. Expression levels of selected 
genes were extracted using R, and for each gene, a linear 
model was constructed using mRNA levels as predictors, 
BMI as a covariate, and BA concentrations as the outcome. 
The same models were constructed stratifying the sample in 
two groups according to low (n=6) or high (n=6) concentra-
tions of the two BAs compared with the median concentra-
tions. Multiple-testing correction was done according to 
Bonferroni: a P-value of 0.016 (=0.05/3) was considered to 
be statistically significant.
Results
There was no difference in age (years) or BMI (kg/m2) 
between the FTO TT, AT, and AA genotype groups (Table 1). 
One subject in the FTO TT genotype group (n=26), three sub-
jects in the FTO AA genotype group (n=18), and no subject 
in the FTO AT genotype group (n=12) had BMI >30 kg/m2.
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In the fasted state, there was no significant difference 
between the levels of the SCD precursors and products, 16:0 
and 16:1n-7, and 18:0 and 18:1n-9, respectively, between the 
three FTO genotype groups (Table 2). However, 2 hours after 
the low-fat breakfast, the level of 16:1n-7 in plasma PL was 
significantly higher (P<0.05) in the FTO AA genotype group 
than in the FTO TT genotype group (Table 2), resulting in 
a significantly elevated (P<0.05) SCD-16 activity index in 
the FTO AA genotype group than in the FTO TT genotype 
group (Figure 1).
Expression of lipogenic genes was investigated 2 hours 
after the low-fat breakfast in a subgroup of the participants, 
eight subjects with FTO TT genotype and four subjects with 
FTO AA genotype. Subgroups were chosen based on the 
amount CDCA and CA produced, ie, including individu-
als (n=6) in the highest and individuals (n=6) in the lowest 
quartile to investigate any CDCA-FXR- and CA-FXR-related 
differences in the expression of lipogenic genes, since no 
significant difference was found in the plasma concentrations 
of CDCA and CA between the FTO TT and AA genotype 
groups 2 hours after the low-fat breakfast (Figure 2). Linear 
regression analysis was then used to assess the relationship 
between the plasma concentrations of CDCA and CA and 
the mRNA levels of SCD, FXR, and SHP. After adjusting 
for BMI, the highest 50% concentrations of CA were nega-
tively (P=0.010) correlated with the level of SCD mRNA 
expression (Table 3), while no significant association was 
Table 1 characteristics of study subjects homozygous for the 
low-risk T allele (TT), heterozygous for the  obesity-risk a allele 
(aT), and homozygous for the obesity-risk a allele (aa)
Genotype TT (n=26) AT (n=12) AA (n=18)
age (years) 25.5 (22–36) 25.0 (22–31) 26.0 (20–33)
BMi (kg/m2) 23.8 (19.9–30.8) 21.9 (19.8–27.8) 24.7 (20.1–35.7)
Notes: Data are presented as median (range). no difference (P>0.05) in age and 
BMi between the study groups was observed; Kruskal–Wallis test.
Abbreviation: BMi, body mass index.
Figure 1 Plasma ScD-16 activity index (16:1n-7/16:0) (medium [range]) derived 
from plasma phospholipids of the subjects with the FTO TT (n=26), aT (n=12), and 
aa (n=18) genotypes at fasted state and 2 hours after the low-fat breakfast (post-
meal state).
Notes: *P<0.05, compared with the FTO TT genotype group at post-meal state. 
One-way anOVa with post hoc Tukey test.
Abbreviations: ScD, stearoyl-coa desaturase.
Table 2 Fatty acid levels (% of total fatty acids) in plasma phospholipids of the FTO TT, aT, and aa genotype groups both at fasted 
state and 2 hours after the low-fat breakfast (post-meal state)
Fatty 
acids
TT (n=26) AT (n=12) AA (n=18)
Fasted Post-meal Fasted Post-meal Fasted Post-meal
16:0 25.87±3.53 25.17±2.72 26.32±1.95 26.33±1.84 25.71±3.56 26.03±2.87
16:1n-7 0.40±0.17 0.37±0.18 0.43±0.14 0.43±0.14 0.46±0.20 0.52±0.27a
18:0 14.09±1.80 13.93±1.85 12.81±1.28b 12.83±1.26b 14.00±1.38 14.22±1.62
18:1n-9 11.21±1.52 11.00±1.51 10.28±1.17 10.18±1.31 10.96±1.15 10.73±1.11
Notes: Data are presented as mean±SD. aP<0.05 compared with the FTO TT genotype group at post-meal state; one-way anOVa with post hoc Tukey test. bP<0.05 
compared with the FTO TT and aa genotype groups at fasted and post-meal states; one-way anOVa with post hoc Tukey test. 
observed for expression mRNA levels of FXR and SHP. No 
significant relationship was observed between the post-meal 
plasma concentrations of CDCA and CA and mRNA levels 
of SCD, FXR, and SHP in the whole FTO genotype groups 
(n=12), in those corresponding to the lowest or the highest 
50% of the CDCA and CA concentrations when unadjusted 
for BMI, or the lowest or the highest 50% concentrations of 
CDCA adjusted for BMI (data not shown).
Plasma CDCA and CA concentrations from a subgroup of 
the participants were analyzed, 16 subjects with the FTO TT 
genotype and eight subjects with the FTO AA genotype. No 
significant difference was found in the plasma concentrations 
of CDCA and CA between the FTO TT and AA genotype 
groups at fasted state or 2 hours after the low-fat breakfast. 
In contrast, 2 hours after the breakfast, the plasma concen-
trations of both CDCA and CA were significantly decreased 
(P<0.05) compared with those concentrations in fasted state 
within each FTO TT and AA genotype groups (Figure 2).
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Discussion
To our knowledge, this is the first study that investigates the 
association between the polymorphic expression of FTO 
(rs9939609) and its relationship with SCD activity indices 
and concentrations of the primary BAs, CDCA and CA, in 
a low-fat diet environment. We noted that after the low-fat 
breakfast, the plasma SCD-16 activity index was significantly 
higher in the young healthy subjects homozygous for the 
FTO rs9939609 obesity-risk A allele than in those homozy-
gous for the FTO rs9939609 wild-type T allele. In addition, 
we observed that after the low-fat breakfast, the plasma 
concentrations of CDCA and CA decreased independently 
of rs9939609 FTO allele variants and that high post-meal 
plasma CA concentrations were negatively correlated with 
the level of mRNA SCD expression when adjusted for BMI.
Table 3 relationship between plasma concentrations of ca and 
gene expression of SCD mrna 2 hours after a low-fat breakfast 
(post-meal state)
 b P-value
Total (n=12)
SCD mrna –0.20 0.454
BMi 0.65 0.035
Lowest 50% (n=6)
SCD mrna –0.47 0.310
BMi 0.50 0.296
Highest 50% (n=6)
SCD mrna –0.82 0.010
BMi 0.88 0.008
Notes: linear regression analyses were performed for the estimation of relationship 
between plasma concentrations of ca as outcome variable and SCD mrna and BMi 
as independent variables.
Abbreviations: BMi, body mass index; ca, cholic acid; SCD, stearoyl-coa 
desaturase.
Figure 2 Plasma concentrations (medium [range]) of the bile acids cDca (left) and ca (right) in the FTO TT (n=16) and aa (n=8) genotype groups at fasted state and 
2 hours after the low-fat breakfast (post-meal state).
Notes: *P<0.05, compared with the fasted state within each genotype group. Wilcoxon signed-rank test.
Abbreviations: ca, cholic acid; cDca, chenodeoxycholic acid.
The FTO gene has been extensively studied in relation to 
dietary macronutrient composition and susceptibility for obe-
sity.7,21 In a population-based prospective cohort study among 
middle-aged subjects in Sweden using dietary data of high 
validity, the subjects homozygous for the FTO rs9939609 
obesity-risk A allele reported higher percentages of energy 
from fat and lower percentages of energy from carbohydrate 
compared with the obese subjects not carrying any FTO risk 
alleles.7 However, no increased risk of obesity was observed 
among the subjects homozygous for the FTO rs9939609 
obesity-risk A allele who consumed <41% of energy from fat. 
The most commonly used measure of obesity in epidemio-
logical studies is BMI >30 kg/m2. In our study, no significant 
difference in BMI was observed between the groups with 
different variants of rs9939609 FTO alleles, which could be 
explained by the fact that only four of the subjects had BMI 
>30 kg/m2, ie, one with the FTO TT genotype (1.8%) and 
three with the FTO AA genotype (5.4%).
Over the last decade, there has been much interest in 
estimating the SCD activity (16:1n-7/16:0 ratio) derived 
from plasma lipids as a putative biomarker for the body fat 
regulation and development of obesity.22 The SCD activity 
has been shown to negatively correlate with cholesterol, to 
positively correlate with TG and plasma very-low density 
lipoprotein,9 and to be highly regulated by food intake.23 
Higher SCD activity in plasma TG has been observed follow-
ing a high-carbohydrate diet compared with a high-fat diet 
both in animals9 and humans.9,24 In addition, a study on mice 
that were deficient in the SCD gene showed that this made 
them resistant to high-carbohydrate diet-induced obesity and 
fatty liver.25 Moreover, higher SCD protein levels in the livers 
were observed in animals fed with a high-carbohydrate diet 
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than in livers of those fed with a high-fat diet.13 Although this 
finding suggests that the SCD enzyme and de novo lipogen-
esis are upregulated in parallel, studies evaluating association 
between SCD activity in the liver and dietary macronutrients 
intake have been somewhat conflicting. There is evidence 
that SCD mRNA expression in the liver is associated with 
the major source of the carbohydrate-derived fatty acids that 
end up as TG in adipose tissue, since high relative expression 
levels of SCD mRNA was observed after a high-carbohydrate 
diet.13,24 Schwenk et al13 indicated that the different effects 
of dietary macronutrients on SCD mRNA expression are 
associated with altered promoter methylation, such that the 
SCD mRNA expression in the liver being affected by both 
hormones (leptin and ghrelin) and dietary macronutrients, 
ie, via epigenetic mechanisms. Our study manifests the data 
that increased genetic susceptibility to obesity is involved 
in lipid metabolism among young healthy normal weight 
subjects with the FTO rs9939609 obesity-risk A allele, since 
the plasma SCD-16 activity index derived from plasma PL 
was significantly higher (P<0.05) than in subjects with the 
FTO rs9939609 wild-type T allele 2 hours after a relatively 
low-fat breakfast (0.020±0.09 [mean±SD] and 0.014±0.006, 
respectively) (Figure 1). We assume that our result strength-
ens the hypothesis that polymorphic expression of the FTO 
gene in a dietary environment is associated with SCD mRNA 
expression in the liver and thereby related to the SCD activity 
index and the development of obesity.
The BA receptor FXR plays a pivotal role in regulating 
the transcription of several genes important for BAs and 
glucose and TG metabolism.17,18,26,27 BA-activated FXR has 
been shown to lead the repression of hepatic lipogenesis by 
reducing the activation of the SCD enzyme in the liver.17,18 
Within the human liver, the acetyl-CoA subunits, originat-
ing mostly from dietary carbohydrates, are the precursors 
of cholesterol from where CDCA and CA are synthesized, 
and also precursors of the components of TG, saturated fatty 
acids, and monounsaturated fatty acids. In hypertriglyceri-
demia mouse models, the expression of genes involved in 
cholesterol biosynthesis had a tendency to decrease, and 
the expression of genes encoding enzymes involved in fatty 
acid and TG biosynthesis in the liver, such as that of SCD1, 
was significantly reduced in livers of CA-treated animals fed 
with chow diet (containing 73.5% carbohydrate and 4.8% fat) 
compared with the livers of non-CA-treated animals on the 
same diet.17 It is known from several experimental studies 
that changes in the activity of SCD indices estimated from 
plasma or tissues are accompanied by simultaneous changes 
in the transcriptional level of the SCD1.28,29 In our study, 
subgroups were chosen based on the amount CA produced, 
ie, including individuals in the highest and lowest quartiles, 
to investigate any CA-FXR-related differences in the expres-
sion of lipogenic genes. In accordance with the findings of 
Watanabe et al,17 we observed that high post-meal plasma 
CA concentrations negatively correlate with the level of SCD 
mRNA expression when adjusted for BMI (Table 3). No such 
correlation was observed for the expression of SHP mRNA 
as could have been expected based on the inverse correlation 
between CA and SCD mRNA. In addition, our study subjects 
with the FTO AA genotype had nonsignificantly lower post-
meal CA concentrations compared with those with the FTO 
TT genotype (Figure 2), which, in general, have the potential 
to act against the unbeneficial high SCD indices through a 
negative correlation with the transcriptional level of the SCD1 
as we observed for high CA concentrations (Table 3). This 
also implies that subjects carrying the FTO AA genotype and 
showing very low CA concentrations may be at especially 
higher risk for obesity due to high SCD activity.
BAs are among the endogenous metabolites with the high-
est variability between subjects, and this large interindividual 
variation of fasting plasma BA concentrations may be deter-
mined by factors such as gender, diet composition, circadian 
oscillations, and individual capacities for the synthesis and 
transport of BAs.30  On the other hand, low intraindividual 
variation is seen in the postprandial state.31 In contrast to 
other reports, Steiner et al32 observed that the primary BA 
concentrations in serum increased dramatically during the 
night and early morning and that there were considerable 
interindividual variations in the time course of the concen-
trations. The authors indicated that the reason for the high 
degree of intraindividual variation in the primary BAs was 
due to the diurnal changes in the primary BAs independently 
of food intake. Furthermore, Steiner et al32 reported that it was 
unlikely that the peak of BA concentrations observed during 
the night reflects increased BA biosynthesis. Steiner et al32 
suggested that the recovered BAs in the bloodstream are of 
intestinal rather than direct hepatic origin. Consistent with 
the study of Steiner et al,32 we observed that fasting CDCA 
and CA concentrations in the subjects with both the FTO TT 
genotype and the FTO AA genotype were higher (CDCA: 
247.0 [15.2–1029.8] and 161.2 [23.4–1848.2] nmol/L, 
median [range], and CA: 248.3 [59.3–1613.0] and 127.6 
[31.6–1118.1] nmol/L, respectively) compared with 2 hours 
after the low-fat breakfast (CDCA: 121.1 [19.2–365.1] and 
66.0 [18.1–575.0] nmol/L and CA: 205.2 [33.9–525.2] and 
69.3 [25.9–650.6] nmol/L, respectively) (Figure 2). The lower 
CDCA and CA concentrations observed in the post-meal 
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plasma of our subjects are consistent with that of normal 
weight subjects having reduced serum primary BAs concen-
trations following either hyperinsulinemic–euglycemic clamp 
or mixed-meal (509 kcal, 28% fat, and 56% carbohydrate).31 
An animal study has demonstrated that dietary glucose and 
insulin are key postprandial regulators that control hepatic BA 
synthesis.33 Our observation that the BA concentrations are 
higher following overnight fasting compared with post-meal 
status may be consistent with the data from rats on a time-
restricted feeding schedule showing a significant day/night 
rhythm in plasma BA concentrations that followed food avail-
ability irrespective of dietary macronutrient composition.34 
However, the coordinated regulation of postprandial glucose 
and BA metabolism in regulating lipid and glucose homeo-
stasis in humans is complex and needs further investigation.
The strength of the present study is the inclusion of young 
healthy subjects, mostly within normal BMI, given the same 
low-fat breakfast. The median (range) post-meal SCD-16 
activity index of the FTO AA genotype group is statistically 
higher compared with that of the FTO TT genotype group 
(Figure 1). However, study with a larger size of samples with 
sufficient statistical power is required to further explore to 
what extent the detected differences are of biological impor-
tance. In addition, the small study sample sizes and the large 
interindividual variability of BA concentrations may be some 
of the major limitations that may preclude the relationship 
between plasma BA concentrations and the gene expressions 
of SCD mRNA, FXR mRNA, and SHP mRNA 2 hours after 
the low-fat breakfast. The SCD is highly regulated (induced) 
by dietary and hormonal factors, such as glucose and insulin, 
among others.35 A study shows that the plasma insulin levels 
are significantly increased after 1 hour, when normal-weight 
subjects are given a high-fat, high-carbohydrate meal after an 
overnight fast.36 The breakfast of our study subjects, which 
consisted mainly of complex carbohydrates with a relatively 
high glycemic index, is digested quickly, which leads to 
elevated blood insulin levels, and stimulation of the blood 
glucose transport into liver, and glucose metabolization. 
According to the study of Patel et al,36 our 2-hour postprandial 
SCD activity indices and concentrations of the primary BAs 
CDCA and CA should show their associations with a genetic 
variant of FTO (rs9939609).
Conclusion
The increased prevalence of obesity is a worldwide health 
concern. In this study, we have shown that carriers of the FTO 
AA (obesity risk) allele may be additively at higher risk for 
obesity, because of the unbeneficial effect of a higher SCD 
activity index, as demonstrated with data obtained in humans 
before and after low-fat (ie, high carbohydrate) dietary intake. 
This risk may be even pronounced for subjects who show very 
low postprandial CA concentrations. Further study requires 
to determine the role of dietary macronutrient composition 
(a low fat vs a high fat) on the SCD activity indices  and 
the primary BA concentrations, whereas understanding the 
development of obesity and metabolic syndrome is essential 
for the prevention and treatment of these disorders.
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